Do Antioxidants Help Muscle Growth? | Educational Video | Biolayne

Norton explains that the same intervention yields opposite outcomes depending on baseline oxidative status. In young people, even moderate doses of antioxidants can blunt hypertrophy and strength gains, as shown by multiple prior studies. In the new elderly study, the antioxidant group not only gained more muscle and strength but also had greater improvements in oxidative status and inflammatory markers. He also alludes to parallel findings with anti-inflammatories: high-dose ibuprofen (>800 mg/day) hinders gains in young, but in elderly, acetaminophen (and likely other anti-inflammatories) appear beneficial. This aligns with the concept that aging shifts the body's internal milieu upward on the U-shaped curve, making interventions that lower inflammation and oxidation advantageous. He emphasizes that broad recommendations should wait until the body of evidence matures, but the mechanism is now supported by human outcome data.

Norton references earlier research showing that young subjects taking high-dose ibuprofen or antioxidants had smaller muscle and strength gains compared to placebo. This effect is consistent with the optimal inflammation window: young individuals have low baseline inflammatory tone, so damping it further is detrimental. In contrast, elderly with sarcopenia, who have elevated inflammatory markers, may benefit from anti-inflammatories (he mentions an acetaminophen study in elderly). He cautions that the negative effect is specifically for high-dose, chronic use—taking an occasional low-dose painkiller for an acute injury is unlikely to cause such adaptation blunting, but the recommendation stands for those intentionally training for hypertrophy or strength.

The study included 60 women aged 60-75 with diagnosed sarcopenia (low skeletal muscle mass index). They were randomized to placebo or 1000 mg vitamin C + 335 mg vitamin E per day while performing 12 weeks of resistance training. Both groups improved, but the antioxidant group had significantly larger increases in muscle mass and strength, as well as greater reductions in oxidative stress markers and inflammatory cytokines. Norton places these results in the context of a U-shaped dose-response: muscle remodeling requires a certain level of reactive oxygen species and inflammatory signaling. Young, healthy individuals already sit in the optimal zone—adding antioxidants or NSAIDs pushes them below the required threshold, hampering gains. Elderly individuals, especially those with sarcopenia, have chronically elevated inflammation and oxidative stress (inflammaging), placing them above the optimal zone. Supplementation brings them back into the beneficial range, enhancing anabolic responses. This mechanistic hypothesis had been proposed before, but the new data provide human-outcome confirmation, highlighting the danger of applying a one-size-fits-all rule to antioxidant use during exercise.